Intermediateimmune
Allergies: When Immunity Overreacts
Overview
Allergies are not immune weakness but immune overreaction: the adaptive system mistakes a harmless substance (pollen, peanuts, dust mites) for a dangerous invader and mounts a full defense. In the most common form, type I hypersensitivity, the body makes IgE antibodies against the allergen, arming mast cells and basophils. On re-exposure, these cells explosively release histamine and other mediators, causing the familiar symptoms from sneezing to life-threatening anaphylaxis. This lesson traces sensitization, the effector phase, symptom mechanisms, and why susceptibility varies.
Learning objectives
- Distinguish sensitization from the effector phase of allergy.
- Explain the roles of IgE, mast cells, and histamine.
- Describe how mediator release produces allergy symptoms.
- Explain anaphylaxis and why epinephrine counteracts it.
Sensitization: arming the mast cells
On first exposure to an allergen, dendritic cells present it to helper T cells, which in susceptible people skew toward a Th2 response, driving B cells to class-switch to IgE instead of IgG. The IgE antibodies circulate and bind tightly to Fc receptors on mast cells (in tissues) and basophils (in blood), arming them. This sensitization phase causes no symptoms; it silently loads the weapons. Genetic predisposition, early-life microbial exposures, and barrier disruptions all influence who becomes sensitized, which is why allergies often run in families.
Sensitization produces no symptoms. The allergy only reveals itself on a later exposure, when armed mast cells meet the allergen again.
Re-exposure: degranulation
When the allergen returns, it cross-links the IgE molecules on a mast cell's surface, triggering explosive degranulation: preformed granules release histamine, proteases, and heparin within seconds, while the cell newly synthesizes prostaglandins, leukotrienes, and cytokines over minutes to hours. This two-wave release explains why allergy symptoms have an immediate phase (sneezing, itching, hives) and sometimes a late phase (prolonged congestion or wheezing hours later). Each mast cell can respond repeatedly, and basophils recruited from blood amplify the reaction.
One IgE binding allergen does nothing; the allergen must bridge two adjacent IgE molecules on the mast cell to fire the degranulation signal.
How mediators cause symptoms
Histamine dilates small blood vessels and makes them leaky (redness, swelling, hives), stimulates mucus glands (runny nose, watery eyes), contracts airway smooth muscle (wheezing), and irritates nerve endings (itching). Prostaglandins and leukotrienes intensify bronchoconstriction and mucus, which is why asthma and allergy often overlap. In the gut, the same mediators speed motility and fluid secretion, causing cramps and diarrhea in food allergy. Every classic allergy symptom is thus a normal defense (expel, dilute, isolate) deployed against the wrong target.
Sneezing expels, mucus traps, itching prompts scratching: the body runs its anti-parasite program against harmless pollen or food proteins.
Anaphylaxis: systemic degranulation
If an allergen reaches the bloodstream (as with insect stings, certain foods, or injected drugs), mast cells and basophils throughout the body degranulate at once. Massive vasodilation and fluid leakage drop blood pressure dangerously, while airway constriction and swelling threaten breathing: this is anaphylaxis, which can be fatal within minutes. Epinephrine (adrenaline) is the emergency treatment because it constricts blood vessels, relaxes airway muscle, reduces swelling, and suppresses further mediator release, directly opposing histamine's effects. People at risk carry epinephrine auto-injectors for immediate use.
Rapid-onset breathing difficulty, throat tightness, dizziness, or collapse after an exposure require immediate emergency care; this lesson explains the physiology, not treatment protocols.
Why some people, and desensitization
Allergy susceptibility reflects genes controlling IgE production and barrier function plus environmental factors: the hygiene hypothesis proposes that reduced early microbial exposure skews the immune system toward Th2/IgE responses. Allergies can also be outgrown as regulation improves. Allergen immunotherapy (desensitization) gives gradually increasing allergen doses over months to years, shifting the response from IgE toward blocking IgG antibodies and inducing regulatory T cells, retraining the system to tolerate the allergen.
Antihistamines block symptoms; immunotherapy gradually rewires the underlying response toward tolerance.
Key points
- Sensitization arms mast cells with IgE silently; re-exposure cross-links IgE and triggers degranulation.
- Histamine causes vasodilation, leakiness, mucus, bronchoconstriction, and itching: defenses aimed at the wrong target.
- Anaphylaxis is systemic degranulation causing dangerous blood pressure drop and airway obstruction.
- Epinephrine opposes these effects: vasoconstriction, airway relaxation, reduced mediator release.
- Immunotherapy retrains the response toward blocking IgG and regulatory T cells.
Common misconceptions
✓ Truth: Allergy is an overactive, misdirected response: the system mounts a full Th2/IgE defense against something harmless.
✓ Truth: Sensitization requires a first exposure; the allergy appears on later encounters after mast cells have been armed with IgE.
✓ Truth: They block histamine's effects on symptoms but do not remove the underlying IgE sensitization; immunotherapy addresses the cause.
Practice questions
Q1. In type I hypersensitivity, sensitization involves:
- IgG coating of pathogens
- Production of IgE that arms mast cells and basophils
- Direct killing by cytotoxic T cells
- Complement-mediated lysis
Th2-driven class switching produces allergen-specific IgE, which binds Fc receptors on mast cells and basophils, arming them for future encounters.
Q2. Mast cell degranulation is triggered when an allergen:
- Binds a single IgE molecule
- Cross-links adjacent IgE molecules on the mast cell surface
- Enters the mast cell nucleus
- Binds complement
Bridging two or more receptor-bound IgE molecules generates the intracellular signal for explosive granule release.
Q3. Histamine's effects during an allergic reaction include:
- Vasoconstriction and reduced mucus
- Vasodilation, increased vascular permeability, and smooth muscle contraction
- Suppression of all immune cells
- Increased blood clotting
Histamine dilates vessels, makes them leaky (swelling, hives), stimulates mucus, contracts airway muscle, and irritates nerves (itching).
Q4. Epinephrine counteracts anaphylaxis primarily by:
- Blocking IgE production
- Constricting blood vessels and relaxing airway smooth muscle
- Dissolving blood clots
- Neutralizing the allergen
Epinephrine reverses vasodilation and bronchoconstriction, reduces edema, and suppresses further mediator release, buying time for emergency care.
Click a question to reveal the answer and explanation.
Frequently asked questions
What is the difference between an allergy and an intolerance?
Allergy is an immune response (typically IgE-mediated) against a substance; intolerance, like lactose intolerance, is a non-immune problem such as an enzyme deficiency. Only allergy involves antibodies and mast cells.
Why do allergies often involve the nose, eyes, and airways?
These surfaces are where airborne allergens land, and they are rich in mast cells. Mediator release there directly produces sneezing, mucus, itching, and wheezing.
Why does epinephrine help in anaphylaxis?
It reverses the key pathological changes: constricting dilated vessels to restore blood pressure, relaxing constricted airways, reducing swelling, and dampening further mast-cell mediator release.
Can adults develop new allergies?
Yes. Sensitization can occur at any age as immune regulation, exposures, and barrier function change over a lifetime.